SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

Neuralstem Inc. (CUR)

CUR RSS Feed
Add CUR Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/5/2017 12:03:26 AM - Followers: 180 - Board type: Free - Posts Today: 0

 

Neuralstem Inc. (CUR)

 

 

http://www.neuralstem.com/

 

 

 

Company Information:

Neuralstem, Inc.
9700 Great Seneca Highway
Suite 240
Rockville, MD 20850

301-366-4841

 

CIK:  0001357459

Neuralstem, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of central nervous system therapies based on its proprietary human neuronal stem cells and stem-cell derived small molecule compounds. The company?s stem cell technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. Its clinical development products include NSI-189, which has completed Phase I clinical trial for the treatment of major depressive disorder, as well as is in Phase I clinical trial for the treatment of other psychiatric and/or cognitive impairment indications associated with hippocampal atrophy; and NSI?566 that has completed Phase II clinical trial for treating amyotrophic lateral sclerosis disease, as well as is in Phase I clinical trials for the treatment of chronic spinal cord injury and motor deficits due to ischemic stroke. The company was founded in 1996 and is headquartered in Germantown, Maryland.

 

 NeuralStem Inc. Announces First Patient Enrolled In Phase 2 Clinical Trial In Major Depressive Disorder
http://www.biospace.com/News/neuralstem-inc-announces-first-patient-enrolled-in/419306

To follow the  Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder

Link here;
https://clinicaltrials.gov/ct2/show/NCT02695472?term=nsi-189&rank=1

 

Management: 

http://investor.neuralstem.com/phoenix.zhtml?c=203908&p=irol-govmanage

 

 

 

 

 

 

 

INTELLECTUAL PROPERTY

At the heart of  Neuralstem's therapeutic cell development programs is the is ability to isolate and grow human neural stem cells from diverse regions of the developing human brain and spinal cord.
 
This technology is supported by our portfolio of issued and pending patents.  The Company has a very pro active plan for obtaining and protecting it's stem cell Intellectual Property, not just in the United States, but world wide.  In addition to it's stem cell intellectual property, the company has been active in licensing in important intellectual property rights for newly developed devices and equipment that will be required to optimize delivery of  it's stem cell therapeutics through surgical transplantation into the brain and spinal cord.

 

Patents Issued

 Number

Country  

 Filing Date

 Issue Date

 Expiration Date

 Title 

 5,753,506

 US

 09/25/96

 05/19/98

 09/25/2016

Isolation, Propagation, and Directed Differentiation of Stem Cell from Embryonic and Adult Central Nervous System of Mammals 

 6,040,180

 US

 05/07/97

 03/21/00

 09/25/2016

In Vitro Generation of Differentiated Neurons from Cultures of Mammalian Multi-potential CNS Stem Cell

 6,284,539

 US 

 10/09/98

 09/04/01

 10/9/2018

Method for Generating Dopaminergic Cells Derived from Neural Precursors

 755849 

 Australia

 09/22/99 

 04/03/03

 09/20/2019

Stable Neural Stem Cell Lines


Investor Information:
http://investor.neuralstem.com/phoenix.zhtml?c=203908&p=irol-IRHome

Recent News: 

http://investor.neuralstem.com/phoenix.zhtml?c=203908&p=irol-news&nyo=0

 

http://finance.yahoo.com/q/h?s=CUR+Headlines

 

 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001357459&type=&dateb=&owner=include&count=40

 

Transfer Agent:

American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038

 

Share Structure:

See filings

Common Stock

Authorized 300,000,000 6/30/16
Issued and Outstanding 2016 114,760,960 7/31/16
Issued and Outstanding 2015 92,005,705 6/30/16


Prefered Stock

Authorized 7,000,000 6/30/16
Issued 0 6/30/16
Outstanding 0 6/30/16


 


 

Investor Relations:

Neuralstem, Inc. 
Phone: 301-366-4960 x1
E-mail:
investor@neuralstem.com

 

 

 

 

 

 



 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

 

Please keep your posts on topic because your message(s) will probably be deleted when:

* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

SureTrader
Interactive Brokers Advertisement
CUR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#4492   Also in CUR. Think it's going higher. 2obee1 10/05/17 12:03:25 AM
#4491   Loaded CUR here with close over the 50dma. pj McMulligan 10/03/17 10:18:32 PM
#4490   It will go higher than that with some mo_doggie 09/28/17 11:43:08 AM
#4489   I would feel good if it cross 1.30 Sunnycupid 09/28/17 11:01:26 AM
#4488   Good price. Me too! mo_doggie 09/28/17 10:36:23 AM
#4487   It’s ready for monthly chart breakout .Needed little Sunnycupid 09/28/17 10:29:22 AM
#4486   * * $CUR Video Chart Analysis 9/21/17 * * ClayTrader 09/21/17 05:38:38 PM
#4485   A lot of action here!!! mo_doggie 09/21/17 10:04:24 AM
#4484   Massive Breakout coming soon here! aristotelisonassis 09/20/17 02:28:24 PM
#4483   $CUR Receives 2 patents !! TradingTickers 09/08/17 09:18:33 AM
#4482   $CUS receives 2 patents !!! TradingTickers 09/08/17 09:17:42 AM
#4481   * * $CUR Video Chart 08-29-17 * * ClayTrader 08/29/17 04:57:42 PM
#4479   Oh Daytrader765 08/13/17 03:55:27 PM
#4478   temporary bottom in 514 08/12/17 01:38:28 AM
#4477   A reverse split was a dumb move!! Satisfying TheRealMrPirate 08/10/17 08:10:11 PM
#4476   Interestingly I got an update from Neuralstem saying ADVFN_gilotron 08/09/17 04:57:53 PM
#4475   yea i've tried it myself and i think ADVFN_gilotron 08/04/17 08:32:01 PM
#4474   it means SDQ has to be primary end gmeetrader 08/03/17 09:05:32 AM
#4473   heya, what do you mean by this:- ADVFN_gilotron 08/02/17 09:58:27 AM
#4472   Stat Sig result on SDQ mirrors several approved gmeetrader 08/01/17 03:02:27 PM
#4471   Offering at 2$. Who will buy at 2$ declaes 07/31/17 01:19:27 PM
#4470   I've got my eyes on this one for Daytrader765 07/29/17 10:08:50 AM
#4469   Holy cow, that chart is one ugelly S mokew 07/27/17 02:13:52 PM
#4468   Phase 2 fail plus dilution. Going to be willlbone 07/27/17 01:22:57 PM
#4467   I'll have to second that :D DezertRat 07/27/17 11:11:23 AM
#4466   TIMBER !!!! Global Supermodel 07/26/17 05:25:54 PM
#4465   .75 a share. Lmao Global Supermodel 07/26/17 05:25:37 PM
#4464   CUR! beat up and left for dead. TheHound 07/26/17 11:33:44 AM
#4463   Up .08 after hours. Spicknspan 07/25/17 05:14:34 PM
#4462   ...based on buying volume in the chart. aristotelisonassis 07/25/17 03:41:41 PM
#4461   Strong rebound based on what? tommsel1 07/25/17 03:39:30 PM
#4460   good buying ooportunity here. Strong rebound is coming! aristotelisonassis 07/25/17 02:32:49 PM
#4459   $CUR. This will just gradually trend up BusterCWK 07/25/17 10:27:30 AM
#4458   wow, big drop Seminole Red 07/25/17 10:25:49 AM
#4457   $CUR. Who cares if it did not BusterCWK 07/25/17 09:43:24 AM
#4456   Nope the exciting times were right around March tkundrat 07/22/17 07:55:42 PM
#4455   YAY Seminole Red 06/26/17 10:11:04 AM
#4454   Interesting... Cbdpotential 06/26/17 09:08:55 AM
#4453   Neuralstem Added to the Russell Microcap Index crowin 06/26/17 08:34:05 AM
#4452   yay Seminole Red 06/23/17 03:32:52 PM
#4451   CUR just hit a new 13 week high crowin 06/23/17 01:21:40 PM
#4450   go baby go Seminole Red 06/22/17 12:07:04 PM
#4449   Had some of this @ 4.16 p/s Bearly Bullish 05/18/17 11:35:07 PM
#4448   Neuralstem Reports Last Subject Out in Phase 2 crowin 05/18/17 07:33:56 AM
#4447   Large fall yesterday gilotron 05/09/17 05:12:10 AM
#4446   nsi-189 patent gilotron 04/30/17 08:29:52 AM
#4445   https://clinicaltrials.gov/ct2/show/NCT01772810 crowin 04/12/17 07:44:07 AM
#4443   Finally.... they ER !!! 08190819 03/23/17 07:51:07 AM
#4442   Now in the news says on 27th.... I 08190819 03/22/17 07:24:15 PM
#4441   Where is that info from? Still no ER out. s_Henderson 03/22/17 03:36:15 PM
PostSubject